Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP173402.RAFFwzUrxPq2BDiH3oHl6HIGXgQxhYXOwl85QqPoatuH8130_assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173402.RAFFwzUrxPq2BDiH3oHl6HIGXgQxhYXOwl85QqPoatuH8130_provenance.
• assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP261100.RAwI70rLICibROw5nTi96q6Mz1i0bpG_Z0a_XEBgpty8I130_assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261100.RAwI70rLICibROw5nTi96q6Mz1i0bpG_Z0a_XEBgpty8I130_provenance.
• NP305972.RAf-_yHk2nWoupopXnLlikKxh-mdDZOTI3cAYL6dRPU5I130_assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305972.RAf-_yHk2nWoupopXnLlikKxh-mdDZOTI3cAYL6dRPU5I130_provenance.
• NP306245.RAe5gochdqqSUBsw_54_WGGSkiz86L39HsyPJKce52sq8130_assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306245.RAe5gochdqqSUBsw_54_WGGSkiz86L39HsyPJKce52sq8130_provenance.
• NP304796.RA_O2cI7WLE4opo_F1uAHYg3G-XBy0Nu1GfiyB7lwlpDg130_assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304796.RA_O2cI7WLE4opo_F1uAHYg3G-XBy0Nu1GfiyB7lwlpDg130_provenance.
• assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP375904.RA5vtvpKMpNzKAxue8PEbfRVSxJcbzf1FFg8sw9r00TS4130_assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375904.RA5vtvpKMpNzKAxue8PEbfRVSxJcbzf1FFg8sw9r00TS4130_provenance.
• NP375898.RAT-fpXk1QHB55PsFFo2Ox2QSvfnvmaNlOS_hegbkZZsw130_assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375898.RAT-fpXk1QHB55PsFFo2Ox2QSvfnvmaNlOS_hegbkZZsw130_provenance.
• NP375902.RAbnP7knjtwWjn_O6wU_-li1WtKJwotdhgphLsxJbPNd8130_assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375902.RAbnP7knjtwWjn_O6wU_-li1WtKJwotdhgphLsxJbPNd8130_provenance.
• NP375900.RAreAuMcIyXW6fJG_SrYB7EjmsIzhnS2XFr1sjs5jNaqM130_assertion description "[We conclude (1) that p16(INK4a) epigenetic inactivation most likely represents an early event, insufficient for malignant transformation, that may occur in clinically benign lesions such as LS; (2) that lack of pRb was only detected in fewer than one quarter of the carcinomas and could be considered a late secondary event; and (3) that cyclin-D1, which was overexpressed in VC and VIN, could contribute to the malignant transformation in association with p16 hypermethylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375900.RAreAuMcIyXW6fJG_SrYB7EjmsIzhnS2XFr1sjs5jNaqM130_provenance.